International Journal of Clinical Oncology

, Volume 19, Issue 2, pp 266–273 | Cite as

Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer

  • Taichiro Goto
  • Arafumi Maeshima
  • Yoshitaka Oyamada
  • Ryoichi Kato
Original Article
First Online:
Received:
Accepted:

Abstract

Background

We investigated the postoperative mortality and long-term survival of lung cancer patients with underlying idiopathic pulmonary fibrosis (IPF).

Methods

The data of 387 primary lung cancer patients treated by surgical resection at our hospital between 1995 and 2008 were retrospectively reviewed. Clinicopathological characteristics such as age, gender, survival, presence/absence of underlying IPF, atypical adenomatous hyperplasia (AAH), and the associations among these factors were examined.

Results

Among the 387 patients, 65 (16.8 %) had underlying IPF as detected by histopathology of the resected specimen (IPF group). The percentages of men and squamous cell carcinomas were significantly higher in the IPF group. None of our patients showed concomitant presence of AAH and IPF. Four of the 65 patients showed acute exacerbation of the IPF postoperatively, and all 4 of these patients died in hospital. In patients with non-small cell lung carcinoma, the postoperative survival tended to be lower in the IPF group than in the non-IPF group. Analysis using a Cox proportional hazards model by disease stage revealed that presence of underlying IPF was a risk factor for postoperative mortality in patients with pathological stage I/II but not for stage III/IV. Respiratory failure was the second main cause of death in the stage I/II lung cancer patients of the IPF group.

Conclusion

Histopathological evidence of IPF was a risk factor for postoperative mortality and poor long-term survival, especially in patients with stage I/II non-small cell lung cancer, with postoperative respiratory failure representing the major cause of death.

Keywords

Idiopathic pulmonary fibrosis Lung cancer Surgery Clinicopathological analysis Mortality Prognosis 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301–1315PubMedCrossRefGoogle Scholar
  2. 2.
    Kawabata Y, Fukushima K, Uchiyama T et al (2001) A focal usual interstitial pneumonia lesion: an important risk factor in diffuse alveolar damage–acute exacerbation of a focal usual interstitial pneumonia patient. Nihon Kokyuki Gakkai Zasshi 39:316–321PubMedGoogle Scholar
  3. 3.
    King TE Jr, Schwarz MI, Brown K et al (2001) Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164:1025–1032PubMedCrossRefGoogle Scholar
  4. 4.
    Reynolds HY (1998) Diagnostic and management strategies for diffuse interstitial lung disease. Chest 113:192–202PubMedCrossRefGoogle Scholar
  5. 5.
    Riha RL, Duhig EE, Clarke BE et al (2002) Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J 19:1114–1118PubMedCrossRefGoogle Scholar
  6. 6.
    Bouros D, Hatzakis K, Labrakis H et al (2002) Association of malignancy with diseases causing interstitial pulmonary changes. Chest 121:1278–1289PubMedCrossRefGoogle Scholar
  7. 7.
    Hubbard R, Venn A, Lewis S et al (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161:5–8PubMedCrossRefGoogle Scholar
  8. 8.
    Park J, Kim DS, Shim TS et al (2001) Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 17:1216–1219PubMedCrossRefGoogle Scholar
  9. 9.
    Gibbs AR, Thunnissen FB (2001) Histological typing of lung and pleural tumours: third edition. J Clin Pathol 54:498–499PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, New YorkGoogle Scholar
  11. 11.
    Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824PubMedCrossRefGoogle Scholar
  12. 12.
    Mori M, Chiba R, Takahashi T (1993) Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis. Cancer (Phila) 72:2331–2340CrossRefGoogle Scholar
  13. 13.
    Goto T, Maeshima A, Akanabe K et al (2011) Acute exacerbation of idiopathic pulmonary fibrosis of microscopic usual interstitial pneumonia pattern after lung cancer surgery. Ann Thorac Cardiovasc Surg 17:573–576PubMedCrossRefGoogle Scholar
  14. 14.
    Chiyo M, Sekine Y, Iwata T et al (2003) Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 126:1141–1146PubMedCrossRefGoogle Scholar
  15. 15.
    Kumar P, Goldstraw P, Yamada K et al (2003) Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 125:1321–1327PubMedCrossRefGoogle Scholar
  16. 16.
    Kawasaki H, Nagai K, Yoshida J et al (2002) Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 81:33–37PubMedCrossRefGoogle Scholar
  17. 17.
    Kutlu CA, Williams EA, Evans TW et al (2000) Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg 69:376–380PubMedCrossRefGoogle Scholar
  18. 18.
    Watanabe A, Higami T, Ohori S, et al (2008) Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 136:1357–1363, 1363.e1–2Google Scholar
  19. 19.
    Martinod E, Azorin JF, Sadoun D et al (2002) Surgical resection of lung cancer in patients with underlying interstitial lung disease. Ann Thorac Surg 74:1004–1007PubMedCrossRefGoogle Scholar
  20. 20.
    Okamoto T, Gotoh M, Masuya D et al (2004) Clinical analysis of interstitial pneumonia after surgery for lung cancer. Jpn J Thorac Cardiovasc Surg 52:323–329PubMedCrossRefGoogle Scholar
  21. 21.
    Utz JP, Ryu JH, Douglas WW et al (2001) High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 17:175–179PubMedCrossRefGoogle Scholar
  22. 22.
    Koizumi K, Hirata T, Hirai K et al (2004) Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 10:340–346PubMedGoogle Scholar
  23. 23.
    Fujimoto T, Okazaki T, Matsukura T, et al (2003) Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg 76:1674–1678 (discussion 1679)Google Scholar
  24. 24.
    Takeuchi E, Yamaguchi T, Mori M et al (1996) Characteristics and management of patients with lung cancer and idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi 34:653–658PubMedGoogle Scholar
  25. 25.
    Hanley ME, King TE Jr, Schwarz MI et al (1991) The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis 144:1102–1106PubMedCrossRefGoogle Scholar
  26. 26.
    Logan PM, Miller RR, Evans K et al (1996) Bronchogenic carcinoma and coexistent bronchioloalveolar cell adenomas. Assessment of radiologic detection and follow-up in 28 patients. Chest 109:713–717PubMedCrossRefGoogle Scholar
  27. 27.
    Suzuki K, Nagai K, Yoshida J et al (1997) The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer (Phila) 79:1521–1526CrossRefGoogle Scholar
  28. 28.
    Matsushita H, Tanaka S, Saiki Y et al (1995) Lung cancer associated with usual interstitial pneumonia. Pathol Int 45:925–932PubMedCrossRefGoogle Scholar
  29. 29.
    Mizushima Y, Kobayashi M (1995) Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases. Chest 108:1272–1277PubMedCrossRefGoogle Scholar
  30. 30.
    Jankowich MD, Rounds SI (2012) Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 141:222–231PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Portillo K, Morera J (2012) Combined pulmonary fibrosis and emphysema syndrome: a new phenotype within the spectrum of smoking-related interstitial lung disease. Pulm Med 2012:867870PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2013

Authors and Affiliations

  • Taichiro Goto
    • 1
  • Arafumi Maeshima
    • 2
  • Yoshitaka Oyamada
    • 3
  • Ryoichi Kato
    • 1
  1. 1.Department of General Thoracic SurgeryNational Hospital Organization Tokyo Medical CenterTokyoJapan
  2. 2.Department of PathologyNational Hospital Organization Tokyo Medical CenterTokyoJapan
  3. 3.Department of Respiratory MedicineNational Hospital Organization Tokyo Medical CenterTokyoJapan

Personalised recommendations